Zhejiang Intime Group Co., Ltd.

Zhejiang Intime Group Co., Ltd. (hereinafter referred to as "Intime Group" or "the Company") is a listed company under Zhejiang International Trade Group, controlled by Zhejiang Provincial State-owned Assets Supervision and Administration Commission. Its predecessor was "Kaidi Silk", with stock code SZ.000411.
In December 2001, through asset restructuring, the Company acquired a controlling stake in Zhejiang Intime Pharmaceutical Co., Ltd. ("Intime Pharmaceutical"), transformed its main business into pharmaceutical distribution, and changed its name to Zhejiang Intime Group Co., Ltd. Intime Pharmaceutical's predecessor was Zhejiang People's Pharmaceutical Company, founded in July 1950; in 1998, four companies—Zhejiang Pharmaceutical Materials Co., Ltd., Zhejiang Pharmaceutical Industry Company, Zhejiang Pharmaceutical Equipment Company, and Zhejiang Pharmaceutical Technology Company—underwent strategic restructuring and merged to form Intime Pharmaceutical. In 2008, Sinochem Group became the controlling shareholder of Intime Group. In 2017, Intime Group returned to the control and management of Zhejiang International Trade Group.
The Company is a leading regional pharmaceutical distribution enterprise, mainly engaged in pharmaceuticals, traditional Chinese medicine, and biological devices, with pharmaceutical professional distribution, modern logistics, e-commerce, production and processing, and terminal retail as its main business formats. Its subsidiaries include Zhejiang Intime Pharmaceutical Co., Ltd., Zhejiang Intime Pharmaceutical Materials Co., Ltd., Zhejiang Medical Device Co., Ltd., and more than 30 other member enterprises, with a sales network covering Zhejiang and radiating across East China. In 2017, the Company's operating revenue was 18.907 billion yuan; at the end of 2017, total assets were 9.083 billion yuan and owners' equity was 1.905 billion yuan. The Company has for many consecutive years been awarded honors such as "Top 500 Chinese Service Enterprises", "Top 100 Chinese Pharmaceutical Distribution Enterprises", "Leading Enterprise in E-commerce of China's Pharmaceutical Industry", "Top 100 Enterprises of Zhejiang Province", "Key Circulation Enterprise of Zhejiang Province", and "Provincial Key Pharmaceutical Reserve Unit of Zhejiang Province". It is a vice-chairman unit of the China Pharmaceutical Commerce Association and the Zhejiang Pharmaceutical Industry Association.
With the vision of becoming "China's * excellent comprehensive pharmaceutical and health service provider", the Company follows the strategic path of "extensive expansion, intensive growth, integrated improvement, innovative development, and ecosystem synergy", consolidates and enhances its core pharmaceutical distribution business, accelerates the development of strategic businesses such as traditional Chinese medicine and health products, biological products, medical devices, smart logistics, information economy, and new pharmaceutical retail, and is committed to building itself into a large modern pharmaceutical and health industry group with a distinct main business, distinctive operations, and advanced management.